A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation
Study Identifier
P19-569
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
This study seeks to assess the effectiveness and safety of venetoclax in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) in a real-world setting across clinical practice in the Russian Federation.
Study Locations
Location
Status
Location
Oncology Dispensary #2 /ID# 215831
Sochi, Krasnodarskiy Kray, Russian Federation, 354057
Status
Not applicable
Location
Moscow State budget healthcare /ID# 212875
Moscow, Moscow, Russian Federation, 125284
Status
Not applicable
Location
Moscow Regional Research and Clinical Institute n.a. Vladimirskiy (MONIKI) /ID# 215830
Moscow, Moscow Oblast, Russian Federation, 129110
Status
Not applicable
Location
Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 212368
Saint Petersburg, Sankt-Peterburg, Russian Federation, 197101
Status
Not applicable
Location
Central City Hospital #7 /ID# 212373
Yekaterinburg, Sverdlovsk Oblast, Russian Federation, 620137
Status
Not applicable
Location
Regional Children's Clinical Hospital of Volgograd /ID# 212366
Volgograd, Volgograd Oblast, Russian Federation, 400138
Status
Not applicable
Showing {first} - {last} of {total} Results